Hemoglobin (Hgb) >= 9 g/dl
Hemoglobin (Hgb) > 8.0 g/dL =< 2 weeks prior to randomization
Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable); obtained within 14 days prior to study entry
Must have hemoglobin (Hgb) ? 9.0 g/dL within 14 days prior to randomization. Must not have required transfusion of red blood cells within 1 week of baseline Hgb assessment.
Hgb ? 10 g/dL
Hemoglobin (HGB) > 8.0 gm/dl
Hemoglobin (Hgb) >= 8 g/dL (with or without transfusion support)
Hemoglobin (Hgb) > 9.0 g/dL, must be obtained within 8 weeks prior to screening for protocol therapy
ELIGIBILITY CRITERIA FOR RANDOMIZATION (STEP 1): Hemoglobin (Hgb) > 9.0 g/dL
Hemoglobin (HgB) >= 9.0 g/dL
Hemoglobin (HgB) >= 9.0 gr/dL
Within 60 days prior to registration on study: Hemoglobin (Hgb) >= 8.0 g/dL (Note: the use of transfusion or other intervention to achieve Hgb >= 8.0 g/dL is acceptable)
Within 14 days prior to registration: Hemoglobin (Hgb) >= 8 g/dl
Hemoglobin >= 10.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10.0 g/dl is NOT allowed)
Hemoglobin (Hgb) > 9.0 g/dL obtained =< 21 days prior to registration
Hemoglobin >= 10.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin (Hgb) >= 10.0 g/dl is acceptable)
Hemoglobin >= 8.0 g/dl, within 21 days prior to registration (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin >= 10.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10.0 g/dl is acceptable)
Hemoglobin >= 8.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dL is acceptable), within 21 days prior to study entry
Hemoglobin (Hgb) >= 8.5
Obtained within 14 days prior to treatment start: Hemoglobin (HGB) >= 9 g/dl
Hemoglobin (HGB) >= 8 g/dL, within 14 days of registration
Hemoglobin (Hgb) >= 8 g/dl
Hemoglobin (Hgb) ? 8 g/dL
Hemoglobin (Hgb) >= 9 g/dL obtained within 14 days prior to registration
Procurement: Hemoglobin (Hgb) > 8.0 g/dl (transfusions allowed)
Patients with Hgb > 8.0 g/dl (transfusion allowed)
Hemoglobin >= 8.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin (Hgb) < 9 g/dL without growth factor or transfusion support
Hemoglobin (Hgb) ? 80 g/L
Hemoglobin (Hgb) < 9 g/dL
Hemoglobin (Hgb) ? 9 g/dL;
Hgb-A1C ? 7.5%;
Hemoglobin (Hgb) > 10 g/dL within 14 days of starting cycle 1 day 1 treatment
Hgb < 10 g/dL
Hemoglobin (Hgb) >= 9.0 g/dl
Hemoglobin (Hgb) >= 8 g/dL
Hemoglobin (HGB) >= 9 g/dL
Hemoglobin (HGB) > 8.0 gm/dL (patients may be transfused to achieve this HGB level);
Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
PROCUREMENT: Hemoglobin (Hgb) > 8.0 (transfusions allowed)
TREATMENT: Hgb > 8.0 g/dL (transfusions allowed)
Hemoglobin (HgB) > 8.0
Hemoglobin (Hgb) > 8.0
Hemoglobin (Hgb) ? 8.0 g/dL, stable for ? 1 week
Hgb > 8.0 (transfusion allowed)
INCLUSION - PROCUREMENT: Hemoglobin (Hgb) > 8.0 (can be transfused)
At least one cytopenia (ANC < 1800/µL or platelet count < 100,000/µL or hemoglobin [Hgb] < 10 g/dL)
Hemoglobin >= 9.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable), obtained within 30 days prior to registration
Hemoglobin (HgB) > 9 g/dL. Must not have required transfusion of red blood cells within 1 week of baseline Hgb assessment.
INCLUSION - INFUSION: Hemoglobin (Hgb) > 8.0 (may be a transfused value)
Hemoglobin (Hgb) > 8.0 gm/dL
Hemoglobin (Hgb) >= 9 g/dL
Hgb-A1C =< 7.5%
PROCUREMENT INCLUSION: Hemoglobin (Hgb) > 8.0 (may be a transfused value)
Hemoglobin (Hgb) >= 9 g/dL (with/without transfusion)
Hemoglobin >= 10.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin (Hgb) >= 10.0 g/dl is acceptable)
Hemoglobin (Hgb) > 9 g/dL, at the screening visit
Hgb ? 9 g/dL
Glycosylated hemoglobin (Hgb A1c) =< 6.5%
Hemoglobin (Hgb) >= 10.0 g/dL
Hemoglobin (Hgb) > 8.0 g/dL (can be transfused)
Hemoglobin ?9 g/dL (transfused Hgb allowed)
Hemoglobin (Hgb) > 8.0 g/dL (can be transfused)
Hemoglobin (Hgb) <9 g/dL
OBTAINED =< 7 DAYS PRIOR TO REGISTRATION: Hemoglobin (Hgb) >= 9.0 g/dL
Hgb > 8.0 (transfusion allowed)
Hemoglobin (Hgb) >= 8 g/dL
Hemoglobin (Hgb) > 9 g/dL.
Glycated hemoglobin (Hgb-A1C) level of =< 7.5%.
Hemoglobin >= 9.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)
Hemoglobin (Hgb) > 8.0 (can be transfused)
INCLUSION - TREATMENT: Hemoglobin (Hgb) ? 9.0 g/dl
Hemoglobin (Hgb) > 9 g/dL
Hemoglobin >= 9.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= g/dl is acceptable)
Hemoglobin > =10 g/dl. The use of transfusion or other intervention to achieve Hgb ?10.0 g/dl is acceptable.
Hemoglobin (Hgb) >= 9 g/dL
Anemia (hemoglobin [Hgb] < 10 g/dL)
Hemoglobin (Hgb) >= 9 g/dL (acceptable to reach via transfusion) obtained within 14 days prior to initiating study treatment.
Hemoglobin (Hgb) >= 9 g/dL.
Hemoglobin (Hgb) >= 8.5 g/dl
Hemoglobin (Hgb) < 8 mg/dl, per PI discretion if thought to be related to underlying myeloma
Hemoglobin (Hgb) >= 8 g/dL
Hemoglobin (HgB) >= 9 g/dL compatible for surgery
Obtained =< 14 days prior to registration: Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin (HgB) < 10 g/dL
Hemoglobin (Hgb) >= 9 g/dL (more than 48 hours post-completion of blood transfusion)
Obtained within 28 days prior to registration: Hemoglobin (Hgb) >= 9 g/dL
Within 28 days prior to registration: Hemoglobin (Hgb) >= 10 g/dL
Hemoglobin (Hgb) >= 9 g/dL (in absence of blood transfusion).
Hemoglobin (Hgb) > 8 g/dL
Hemoglobin (Hgb) ? 9.0 g/dL
Hemoglobin (Hgb) =< 10.0 or
Hemoglobin (Hgb) > 7.5 gm/dL
Obtained within 28 days prior to registration: hemoglobin (Hgb) >= 8.0 g/dl; Note: The use of transfusion or other intervention to achieve Hgb >= 8.0 g/dl is acceptable
Within 4 weeks of day 1: Hemoglobin (HgB) >= 10.0 gr/dL independent of transfusion
Hemoglobin (Hgb) ? 9 g/dL obtained ? 14 days prior to randomization; patient may receive transfusion as needed
Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin (Hgb) >= 9 g/dL.
Hemoglobin (Hgb) < 8 mg/dl
Hemoglobin (HgB) >= 9.0 g/dL
Hemoglobin (Hgb) >= 9 g/dL or >= 5.6 mmol/L without (w/o) transfusion within 7 days of assessment.
Hemoglobin (Hgb) >= 9 g/dL; (last transfusion cannot be within 7 days of trial initiation)
Hemoglobin (Hgb) >= 9 g/dL (within 16 days before starting therapy)
Hgb >= 10 g/dL ((within 16 days before starting therapy)
Hemoglobin (HGB) >= 10 g/dl
HGB of > 10 g/L
Hemoglobin (Hgb) > 8.0 g/dL
Hemoglobin (HgB) >= 9.0 g/dL
Hemoglobin >= 8.0 g/dl; Note: the use of transfusion or other intervention to achieve hemoglobin (Hgb) >= 8.0 g/dl is acceptable
Hemoglobin (Hgb) >= 10 g/dL (use of transfusion to reach this threshold prior to study initiation is acceptable)
Within 14 days prior to cycle 1 day 1 of treatment: Hemoglobin (Hgb) >= 9.0 g/dL
Hemoglobin (Hgb) >= 9 g/dl
Hemoglobin (HGB) > 9.0 g/dL, within 30 days before study registration
Hemoglobin (Hgb) >= 9.0 g/dL
Within 4 weeks prior to the registration: hemoglobin >= 8.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin (Hgb) > 8.0 gm/dL
Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin (HGB) >= 7 g/dl without transfusion or growth factor support for at least 1 week
Hemoglobin (Hgb) >= 10 g/dl within 30 days of enrollment to study
Hemoglobin (Hgb) >= 9 g/dL (obtained within 28 days prior to first study treatment)
Hemoglobin (Hgb) > 8.5 g/dL
Hemoglobin (Hgb) > 9.0 g/dL, within 14 days prior to treatment
Hemoglobin (Hgb) >= 9 g/dL.
Hemoglobin (Hgb) >= 9 g/dL, within 14 days start of study start
Hemoglobin (Hgb) >= 8 g/dL
Hemoglobin (Hgb) >= 9.0 g/dL
Hemoglobin (Hgb) ? 9 g/dL
Hemoglobin (Hgb) >= 10 g/dL; eligibility level for hemoglobin may be reached by transfusion, within 14 day prior to registration
Hemoglobin (HGB) < 8 g/dL
Hemoglobin (Hgb) >= 9.0 gm/dl
Hemoglobin (Hgb) >= 8 gr/dL
Hemoglobin (Hgb) >= 9 g/dL
EXCLUSION CRITERIA FOR PATIENTS WITH NSCLC OR TNBC (COHORT B): Hemoglobin (Hgb) < 9 mg/dl (transfusion permitted to achieve this)
Obtained =< 14 days prior to registration: Hemoglobin (HgB) >= 9.0 g/dL
PRIOR TO CELL PROCUREMENT: Hemoglobin (Hgb) ? 8.0 g/dL (transfusion independent for 2 weeks prior to enrollment)
Hemoglobin (Hgb) > 8 g/dl
Hemoglobin (Hgb) >= 9 g/dL without transfusions
Hemoglobin (Hgb) ? 90 g/L (9 g/dL).
Hemoglobin (Hgb) >= 9.0 g/dL
Hemoglobin (HgB) >= 9.0 g/dL
Within 14 days prior to registration: Hemoglobin (Hgb) >= 9.0 g/dL
Hemoglobin (Hgb) >= 8 g/dL
Hgb ?10 g/dL - can be transfused
Within 3 months of registration: Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin (Hgb) >= 9 g/dL (transfusions allowed)
Hgb ? 9 g/dL
Within 14 days prior to study entry: Hemoglobin (Hgb) > 9.0 g/dL (with or without transfusion)
Within 6 weeks of day 1: Hemoglobin (HgB) >= 9.0 gm/dL
Hemoglobin (Hgb) > 10 within 30 days of consent
Hemoglobin (Hgb) > 9 within 45 days of consent
Hemoglobin (Hgb) >= 10.0 gm/dl within 14 days of study entry
Hemoglobin (HgB) >= 9 g/dL
AT THE TIME OF INFUSION: Hemoglobin (Hgb) ? 8.0
Hemoglobin (Hgb) >= 9 g/dL
TREATMENT: Hemoglobin (Hgb) > 8.0 g/dL
Hemoglobin (HGB) >= 9 g/dl (please note: it is acceptable from the standpoint of study eligibility to undergo transfusion in order to achieve hemoglobin >= 9 g/dl)
Hemoglobin (Hgb) <9 g/dL
Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin (Hgb) >= 8
PROCUREMENT: Hemoglobin (Hgb) > 8.0 (transfusions allowed)
TREATMENT: Hgb > 8.0 (transfusion allowed)
Hemoglobin (Hgb) >= 8 g/dL
Hemoglobin (Hgb) >= 9.0 g/dL
Hemoglobin (Hgb) > 8.0 (may be transfused).
Hemoglobin (Hgb) >= 9 g/dl, obtained =< 14 days prior to registration
Hemoglobin (Hgb) greater than 10 g/L
Within 2 weeks of enrollment: Hemoglobin >= 10 g/dl; (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10 g/dl is acceptable)
Hemoglobin (Hgb) > 9 g/dL
Within 30 days of first vaccination: Hemoglobin (Hgb) >= 10 g/dl
Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin (HgB) > 8.0
Hemoglobin (Hgb) >= 9.0 g/dL (obtained =< 7 days prior to registration)
Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin (Hgb) >= 9
Hemoglobin >= 9.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= g/dl is acceptable)
Hemoglobin (Hgb) >= 9 g/dL
Within 14 days prior to registration: Hemoglobin (Hgb) >= 9.0 g/dL (note: the use of transfusion or other intervention to achieve Hgb >= 9.0 is acceptable)
Hemoglobin (Hgb) >= 9.0 g/dL
Hgb > 8.0
Hemoglobin >= 8.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin (Hgb) >= 10 g/dl
Hemoglobin >= 10.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10.0 g/dl is acceptable)
Hemoglobin >= 8 g/dl (Note: the use of transfusion to achieve hemoglobin [Hgb] >= 8 g/dl is acceptable)
Hemoglobin (HgB) >= 9.0 g/dL
Hemoglobin (Hgb) >= 8.5 g/dL
Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin (Hgb) >= 10 g/dl
Hemoglobin (HGB) >= 9 g/dL
Hemoglobin (Hgb) > 8.0 (may be a transfused value)
Hemoglobin (Hgb) >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve Hgb >= 8.0 g/dL is acceptable)
At least one laboratory abnormality probably or definitely attributed to KSHV-MCD\r\n* Anemia (hemoglobin [Hgb] [men] =< 12.5 gm/dL, Hgb [women] =< 11 gm/dL)\r\n* Thrombocytopenia (=< 130,000/mm^3)\r\n* Hypoalbuminemia (< 3.4 g/dL)
Hemoglobin (Hgb) < 8 g/dL
Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] > 8.0 g/dl is acceptable)
Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin (Hgb) > 8.0
Hemoglobin (Hgb) > 9 g/dL
Hemoglobin (Hgb) >= 9.0 g/dl
Hemoglobin (Hgb) >= 9 g/dl
Hemoglobin (Hgb) >= 9.0 g/dL
Hemoglobin (HgB) > 9.0 g/dL; NOTE: subjects may not have had a transfusion within 7 days of registration
Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin (Hgb) >= 9 g/dL
Within 14 days prior to registration: Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin (HgB) >= 9 g/dL for mono-therapy
Hemoglobin (Hgb) >= 9 g/dL without transfusions
Hemoglobin (Hgb) ? 9 g/dL
Hemoglobin (Hgb) ? 9 g/dL
Hemoglobin (HgB) >= 9.0 g/dL
Hemoglobin (Hgb) less than or equal to 8 g/dL
Hemoglobin (Hgb) > 8 g/dL
To be performed within 28 days prior to day 1 of protocol therapy: Hemoglobin (Hgb) >= 8 g/dL without transfusions
Hemoglobin >= 9.0 g/dl; (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)
Within 14 days prior to step 1 registration: Hemoglobin >= 9.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)
Hemoglobin: >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin (Hgb) >= 8 g/dL, obtained within 14 days prior to registration for protocol therapy
Hemoglobin (HgB) > 9.0 g/dL
Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Obtained within 30 days prior to registration: Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin (Hgb) >= 9.0 g/dL
Hemoglobin (Hgb) >= 8 g/dL
Hemoglobin (Hgb) >= 9.0 g/dL
Hemoglobin (Hgb) < 9 g/dL
Hemoglobin >= 9.0 g/dL (patients may be transfused to meet hemoglobin [Hgb] requirement)
Hemoglobin (Hgb) > 9 g/dL
Hemoglobin (Hgb) >= 9.0 gm/dL
Hemoglobin >= 10.0 mg/dl (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10.0 g/dl is acceptable)
Hemoglobin (Hgb) > 10
Hemoglobin >= 8.0 g/dl; Note: the use of transfusion or other intervention to achieve hemoglobin (Hgb) >= 8.0 g/dl is acceptable; within 14 days prior to registration
Hemoglobin >= 8.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin >= 8.0 g/dl (NOTE: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin (HgB) >= 9.0 g/dL
Hemoglobin (Hgb) >= 8.0 g/dL (Note: the use of transfusion or other intervention to achieve Hgb >= 8.0 g/dL is acceptable)
Hemoglobin (Hgb) >= 8.0 g/dL
Hemoglobin (Hgb) >= 8 g/dl (transfusion acceptable)
Hemoglobin (Hgb) >= 10.0 g/dL (note: the use of transfusion or other intervention to achieve Hgb >= 10.0 g/dL is acceptable)
Hemoglobin >= 8.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin (Hgb) >= 9.0 g/dL (Note: the use of transfusion or other intervention to achieve Hgb >= 9.0 g/dL is acceptable)
Hemoglobin >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dL is acceptable)
Hemoglobin (Hgb) >= 9.0 g/dL (transfusions allowed)
Hemoglobin >= 10.0 g/dL (note: the use of transfusion or other intervention to achieve Hgb >= 10.0 g/dl is acceptable)
Hemoglobin (Hgb) >= 9.0 g/dl
Hemoglobin (Hgb) > 8.0
Anemia (hemoglobin [Hgb] < 10 g/dL)
HGB ?10 g/dl and not transfusion dependent
Hemoglobin (Hgb) ? 90 g/L,
Hemoglobin (Hgb) ? 9.0 g/dL
Hemoglobin (Hgb) >= 8.0 g/dL (transfusion or other intervention to achieve Hgb >= 8.0 g/dl is acceptable)
Hemoglobin >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hgb > 9 g/dL
Hemoglobin (Hgb) ? 9 g/dL
Hemoglobin (Hgb) ? 9 g/dl
Hemoglobin (HgB) > 9 g/dL (acceptable to reach this by transfusion)
Hemoglobin >= 8.0 g/dl (Note: use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin (Hgb) ? 9 g/dL.
Hgb ?9 g/dL
Hemoglobin (Hgb) ? 9 g/dl
Hemoglobin (HgB) >= 9
Within 14 days of study start: Hemoglobin (Hgb) >= 9 g/dL (may transfuse if clinically indicated)
Hemoglobin (Hgb) > 9 g/dL (can be achieved with transfusion)
Hemoglobin (Hgb) > 9 g/dL
Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin (Hgb) > 9 g/dL
Hemoglobin (Hgb) > 8.0 g/dL
Hemoglobin (Hgb) > 8.0
Hemoglobin >= 10.0 g/dL (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10.0 g/dl is acceptable)
Hemoglobin >= 8.0 g/dL (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8 g/dl is acceptable)
Hemoglobin (Hgb) >= 8 gm/dL (transfusion independent)
Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin (Hgb) >= 8 g/dL
Hemoglobin (HgB) ?9 g/dL.
Hemoglobin (Hgb) >= 9.0 g/dL (no red blood cell [RBC] transfusion within past 14 days)\r\n* Hgb >= 8.0 g/dL for patients with anemia associated disease
Glycosylated hemoglobin (Hgb A1C) > 8.0%
Hemoglobin (Hgb) >= 10 g/dL (within 16 days before starting therapy)
Hemoglobin (Hgb) > 9
Hemoglobin (Hgb) > 9 g/dl
Obtained within 14 weeks prior to registration on study: hemoglobin >= 8.0 g/dl (the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin (Hgb) > 9.0 g/dL obtained within 14 days prior to registration
Hemoglobin (Hgb) >= 9 g/dL (which may be post transfusion)
Hemoglobin (Hgb) greater than or equal to 9 g/dL
Hemoglobin (HGB) >= 10 g/dl
Hemoglobin (Hgb) >= 9.5 g/dL (transfusion before treatment is allowable if more than 3 days prior to study start)
Hemoglobin (Hgb) > 10 g/dL
Hemoglobin (Hgb) > 10 g/dL
Hemoglobin (Hgb) >= 9.0 g/dL (90 g/L) without blood transfusion within 7 days
Hemoglobin >= 10 g/dl based on CBC/differential obtained within 21 days prior to study registration (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10 g/dl is acceptable)
Hemoglobin >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dL is acceptable)
Hemoglobin (HgB) >= 10.0 g/dL
Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin (Hgb) >= 8 g/dL
Hemoglobin (Hgb) greater than or equal to 9 g/dL (transfusions are allowed)
AT THE TIME OF INFUSION: Hemoglobin (Hgb) > 8.0g/dl (can be transfused)
Hemoglobin (Hgb) >= 9.0 g/dL
hemoglobin (Hgb) > 9.9 g/dL
Hemoglobin (Hgb) A1C =< 8%
Hemoglobin (HgB) >= 9.0 g/dL
Hemoglobin >= 8.0 g/dl within 30 days prior to registration; Note: the use of transfusion or other intervention to achieve hemoglobin (Hgb) >= 8.0 g/dl is acceptable
Hemoglobin (HGB) >= 8 g/dL
Hemoglobin (Hgb) >= 10 g/dl
Hemoglobin (Hgb) >= 9 gm/dL
Hemoglobin (Hgb) >= 10 g/dL (within 16 days before starting therapy)
Hemoglobin (Hgb) >= 8 g/dl
Hemoglobin (Hgb) >= 8.5 g/dL
Hemoglobin (Hgb) >8.0gm/dL
Obtained within 2 weeks from study entry: Hemoglobin (HgB) >= 9 g/dL
Hemoglobin (Hgb) >= 9 g/dl
Hemoglobin (Hgb) ? 10 g/dl
Hemoglobin (Hgb) ? 10 g/dl.
Hemoglobin (Hgb) ? 9.0 g/dL
Hemoglobin (Hgb) < 7.0
Obtained =< 7 days prior to registration: Hemoglobin (Hgb) > 9.0 mg/dl
Hemoglobin >= 9.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)
Hemoglobin (Hgb) >= 9.0 g/dl
Hemoglobin (hgb) =< 10.0 or
Hemoglobin (HgB) >= 9.0 mg/dL
Hemoglobin (Hgb) >= 9 gm/dL (unless due to bone marrow infiltration by tumor in which case Hgb > 8 gm/dL)
Hemoglobin (Hgb) > 8.0 g/dl
Hemoglobin (Hgb) >= 10 g/dL (use of transfusion to reach this threshold prior to study initiation is acceptable)
Hemoglobin (Hgb) >= 9 mg/dL (which may be post transfusion)
Hemoglobin (Hgb) >= 9 g/dL may be supported by transfusion and/or hematopoetic growth factors
Hemoglobin (Hgb) >= 9g/dL
Hemoglobin (Hgb) >= 9.0 g/dL
Hemoglobin (Hgb) >= 9.0 g/dL (transfusion allowed), within 14 days of registration
Hemoglobin (Hgb) > 9 g/dL
Hemoglobin (Hgb) >= 9 g/dl
Hemoglobin (HGB) >= 8 gm/dL
Hemoglobin (Hgb) ? 9.0 g/dL
Hemoglobin (Hgb) >= 9.0 g/dL
Hemoglobin ? 8.0 g/dl (Note: The use of transfusion or other intervention to achieve Hgb ?8.0 g/dl is acceptable).
Hemoglobin (Hgb) > 8.0
Hemoglobin >= 8.0 g/dl (NOTE: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin (Hgb) >= 9 g/dL without transfusions
Hemoglobin (Hgb) ? 9 g/dL.
Hemoglobin >= 9.0 g/dl; (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)
Hemoglobin (Hgb) < 9 g/dL
Participants requiring blood transfusions to maintain hemoglobin (Hgb) eligibility
Hemoglobin (Hgb) ?10 g/dL
Hemoglobin (HgB) > 9.0 g/dL
Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin (Hgb) >= 10 g/dL
Hemoglobin (Hgb) >= 10 g/dL
Hemoglobin (Hgb) >= 9.0 g/dl
Hemoglobin (Hgb) ? 9.0 g/dL
SELUMETINIB ARM: Hemoglobin (Hgb) < 9.0 g/dL
Hemoglobin (HgB) >= 8.0 g/dL
Hemoglobin (Hgb) >= 9 g/L
Hemoglobin (Hgb) >= 10 g/dL
Hemoglobin (Hgb) >= 9.0 g/dL
HgB < 9 g/dL
Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin (HgB)>8.0 (may be transfused)
Hemoglobin (Hgb) >= 9 g/dL
HGB >9.0 g/dL
Hemoglobin (Hgb) ? 9.0 g/dL;
Hemoglobin (Hgb) ? 9 g/dL.
Hemoglobin (HgB) >= 9 g/dL
Hemoglobin (Hgb) ? 9.0 g/dL within 14 days prior to randomization. Must not have required transfusion within 1 week of baseline Hgb assessment.
Hemoglobin (Hgb) >= 9.0 g/dL
Hemoglobin (Hgb) >= 9 g/dL without transfusions
Does the subject have a Hgb ? 10 g/dL?
Hemoglobin (Hgb) ? 9 g/L
Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin (Hgb) >= 9.0 g/dL
Hemoglobin (Hgb) >= 9.0 g/dL obtained =< 7 days prior to registration
Hemoglobin (Hgb) ? 9 g/dL.
Hgb > 7.5 g/dl (without transfusion within 7 days)
Hemoglobin (Hgb) ? 8.0 g/dL at Baseline (within 24 hours prior to surgical procedure).
Hemoglobin (Hgb) > 9 g/dL
Hemoglobin (Hgb) ? 8.0 g/dL
Hemoglobin (Hgb) ? 9 g/dL
Hemoglobin (Hgb) > 9 g/dL
Hemoglobin (Hgb) > 9 g/dL
Hemoglobin (HGB) >= 9 gm/dL
Hemoglobin (Hgb) >= 10.0 gm/dL (Note: the use of transfusion or other intervention to achieve Hgb >= 10.0 is acceptable)
Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin (HgB) > 8.5 g/dL
Hemoglobin (Hgb) ?9.5 g/dl
Hemoglobin (Hgb) A1C =< 8%
Hemoglobin (Hgb) A1C =< 8%
Hemoglobin (HgB) > 9.0 g/dL
Bone marrow: Absolute Neutrophil Count (ANC) ? 1.5 x 109/L, Hemoglobin (Hgb) ? 9 g/dL, Platelets ? 100 x 109/L
Hemoglobin (Hgb) >= 9.0 g/dl
Hemoglobin (Hgb) > 9.0 gms/dl
Hemoglobin (Hgb) > 8.0 g/dl
Hemoglobin (Hgb) >= 8 g/dL
Hemoglobin (Hgb) >= 9 g/dL without transfusions
Hemoglobin (Hgb) > 9 g/dL
Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin >= 9.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)
Hemoglobin >= 10.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 10.0 g/dl is acceptable)
Hemoglobin ? 9.0 g/dl (Note: The use of transfusion or other intervention to achieve Hgb ? 9.0 g/dl is acceptable.)
Evidence of iron deficiency anemia including, hemoglobin (Hgb) < 11 g/dL, but > 8 g/dL; and transferrin saturation (TSAT) < 20%
Severe anemia with hemoglobin (HGB) < 10
Subjects who have diabetes with a hemoglobin (Hgb) A1c > 7
Hemoglobin (Hgb) ? 9.0 g/dL
Hemoglobin (Hgb) >= 9 g/dL or >= 5.6 mmol/L
Hemoglobin (HgB) >= 9.0 g/dL
Hemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin (Hgb) ?>= 8.0 g/dL
Hemoglobin (Hgb) >= 9.0
Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin (Hgb) > 8.0
Hemoglobin (Hgb) > 8.0 g/dL
Hgb ? 9 g/dL
Hemoglobin (Hgb) >= 10 g/dl within 90 days of enrollment
Hemoglobin (Hgb) >= 8.0g/dL
Hemoglobin (Hgb) within normal limits for institution/lab
Hemoglobin (Hgb) ? 8 g/dL.
Hemoglobin (Hgb) > 10.0 g/dL with no blood transfusion in the past 28 days
Hemoglobin (Hgb) ? 10 g/dl
Hemoglobin (Hgb) > 8.0
Hemoglobin (hgb) ? 8.0 g/dL (may be supported with transfusion)
Obtained within 28 days prior to registration: Hemoglobin (Hgb) >= 9 g/dL
Hemoglobin (Hgb) >= 9 g/dL (90 g/L); < 9 g/dL (< 90 g/L) is acceptable if Hgb is corrected to >= 9 g/dL (90 g/L) as by growth factor or transfusion prior to PET scan, obtained within 14 days prior to PET scan
Hemoglobin (Hgb) >= 9 g/dL or >= 5.6 mmol/L without transfusion or erythropoietin (EPO) dependency (within 7 days of assessment of Hgb), obtained within 14 days prior to C11-AMT PET scan
Hemoglobin (hgb) > 10 G/dL
Hemoglobin >= 8.0 g/dl (the use of transfusion or other invention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin >= 8.0 g/dl (The use of transfusion or other invention to achieve Hemoglobin [Hgb] >= 8.0 g/dl is acceptable)
Hemoglobin (HgB) > 9 mg/dL
